149 related articles for article (PubMed ID: 7983770)
1. Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.
Fang H; Pincus SH
J Virol; 1995 Jan; 69(1):75-81. PubMed ID: 7983770
[TBL] [Abstract][Full Text] [Related]
2. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
[TBL] [Abstract][Full Text] [Related]
3. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
Wakefield JK; Rhim H; Morrow CD
J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
[TBL] [Abstract][Full Text] [Related]
4. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.
Chen BK; Gandhi RT; Baltimore D
J Virol; 1996 Sep; 70(9):6044-53. PubMed ID: 8709227
[TBL] [Abstract][Full Text] [Related]
5. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.
Duensing TD; Fang H; Dorward DW; Pincus SH
J Virol; 1995 Nov; 69(11):7122-31. PubMed ID: 7474132
[TBL] [Abstract][Full Text] [Related]
6. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
Ashorn P; Englund G; Martin MA; Moss B; Berger EA
J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626
[TBL] [Abstract][Full Text] [Related]
8. Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.
Ashorn P; Moss B; Berger EA
Ann N Y Acad Sci; 1990; 616():149-54. PubMed ID: 2078015
[TBL] [Abstract][Full Text] [Related]
9. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
[TBL] [Abstract][Full Text] [Related]
11. Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.
Ashorn P; Moss B; Berger EA
J Acquir Immune Defic Syndr (1988); 1992; 5(1):70-7. PubMed ID: 1738090
[TBL] [Abstract][Full Text] [Related]
12. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
Wakefield JK; Kang SM; Morrow CD
J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
[TBL] [Abstract][Full Text] [Related]
13. CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro.
Tsubota H; Winkler G; Meade HM; Jakubowski A; Thomas DW; Letvin NL
J Clin Invest; 1990 Nov; 86(5):1684-9. PubMed ID: 2243139
[TBL] [Abstract][Full Text] [Related]
14. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
15. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
16. A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone.
Imai H; Maotani-Imai K; Shin YS; Ikuta K; Suehiro S; Kurimura T; Kato S; Hirai K
Virus Genes; 1991 Jan; 5(1):81-8. PubMed ID: 2017879
[TBL] [Abstract][Full Text] [Related]
17. Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cells.
Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1091-6. PubMed ID: 8312052
[TBL] [Abstract][Full Text] [Related]
18. Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells.
Zaides V; Yagello M; Veselovskaya T; Schmitt D; Rykova L; Fenouillet E; Gluckman JC
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2963-75. PubMed ID: 7964606
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.
Pincus SH; Wehrly K; Cole R; Fang H; Lewis GK; McClure J; Conley AJ; Wahren B; Posner MR; Notkins AL; Tilley SA; Pinter A; Eiden L; Teintze M; Dorward D; Tolstikov VV
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1041-51. PubMed ID: 8827220
[TBL] [Abstract][Full Text] [Related]
20. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
